N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide

C90H127Cl3N20O11 — CID 159245965

IUPACN-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide
SMILESCC(C)(C)OCCC(=O)Nc1nc2ccc(Cl)nc2n1C(C)(C)C.CC(C)(C)OCCC(=O)Nc1nc2ccc(Cl)nc2n1C1CCOCC1.CC1(C)CCC[C@H](CC(=O)Nc2nc3ccc(Cl)nc3n2C(C)(C)C)O1.Cc1ccc2nc(NC(=O)CC3CCC(C)(C)O3)n(C3CCC3)c2n1.Cc1ccc2nc(NC(=O)CCOC(C)C)n(C3CCC3)c2n1
InChIInChI=1S/C19H27ClN4O2.C19H26N4O2.C18H25ClN4O3.C17H25ClN4O2.C17H24N4O2/c1-18(2,3)24-16-13(8-9-14(20)22-16)21-17(24)23-15(25)11-12-7-6-10-19(4,5)26-12;1-12-7-8-15-17(20-12)23(13-5-4-6-13)18(21-15)22-16(24)11-14-9-10-19(2,3)25-14;1-18(2,3)26-11-8-15(24)22-17-20-13-4-5-14(19)21-16(13)23(17)12-6-9-25-10-7-12;1-16(2,3)22-14-11(7-8-12(18)20-14)19-15(22)21-13(23)9-10-24-17(4,5)6;1-11(2)23-10-9-15(22)20-17-19-14-8-7-12(3)18-16(14)21(17)13-5-4-6-13/h8-9,12H,6-7,10-11H2,1-5H3,(H,21,23,25);7-8,13-14H,4-6,9-11H2,1-3H3,(H,21,22,24);4-5,12H,6-11H2,1-3H3,(H,20,22,24);7-8H,9-10H2,1-6H3,(H,19,21,23);7-8,11,13H,4-6,9-10H2,1-3H3,(H,19,20,22)/t12-;;;;/m1..../s1
InChIKeyKURMDRXZGRNSBH-HHUWXINPSA-N
MW1771.49 g/mol
LogP19.05
Rot. Bonds22

About N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide

N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide (PubChem CID 159245965) has the molecular formula C90H127Cl3N20O11 and a molecular weight of 1771.49 g/mol. Its IUPAC name is N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide.

Molecular Properties

Compound NameN-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide
PubChem CID159245965
Molecular FormulaC90H127Cl3N20O11
Molecular Weight1771.49 g/mol
Exact Mass1768.91
IUPAC NameN-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide
SMILESCC(C)(C)OCCC(=O)Nc1nc2ccc(Cl)nc2n1C(C)(C)C.CC(C)(C)OCCC(=O)Nc1nc2ccc(Cl)nc2n1C1CCOCC1.CC1(C)CCC[C@H](CC(=O)Nc2nc3ccc(Cl)nc3n2C(C)(C)C)O1.Cc1ccc2nc(NC(=O)CC3CCC(C)(C)O3)n(C3CCC3)c2n1.Cc1ccc2nc(NC(=O)CCOC(C)C)n(C3CCC3)c2n1
InChIInChI=1S/C19H27ClN4O2.C19H26N4O2.C18H25ClN4O3.C17H25ClN4O2.C17H24N4O2/c1-18(2,3)24-16-13(8-9-14(20)22-16)21-17(24)23-15(25)11-12-7-6-10-19(4,5)26-12;1-12-7-8-15-17(20-12)23(13-5-4-6-13)18(21-15)22-16(24)11-14-9-10-19(2,3)25-14;1-18(2,3)26-11-8-15(24)22-17-20-13-4-5-14(19)21-16(13)23(17)12-6-9-25-10-7-12;1-16(2,3)22-14-11(7-8-12(18)20-14)19-15(22)21-13(23)9-10-24-17(4,5)6;1-11(2)23-10-9-15(22)20-17-19-14-8-7-12(3)18-16(14)21(17)13-5-4-6-13/h8-9,12H,6-7,10-11H2,1-5H3,(H,21,23,25);7-8,13-14H,4-6,9-11H2,1-3H3,(H,21,22,24);4-5,12H,6-11H2,1-3H3,(H,20,22,24);7-8H,9-10H2,1-6H3,(H,19,21,23);7-8,11,13H,4-6,9-10H2,1-3H3,(H,19,20,22)/t12-;;;;/m1..../s1
InChIKeyKURMDRXZGRNSBH-HHUWXINPSA-N
XLogP19.05
TPSA354.43 Ų
H-Bond Donors5
H-Bond Acceptors26
Rotatable Bonds22
Heavy Atoms124
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001771.49
LogP ≤ 519.05
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide?
The IUPAC name of N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide (CID 159245965) is N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide.
What is the SMILES notation for N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide?
The canonical SMILES for N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide is CC(C)(C)OCCC(=O)Nc1nc2ccc(Cl)nc2n1C(C)(C)C.CC(C)(C)OCCC(=O)Nc1nc2ccc(Cl)nc2n1C1CCOCC1.CC1(C)CCC[C@H](CC(=O)Nc2nc3ccc(Cl)nc3n2C(C)(C)C)O1.Cc1ccc2nc(NC(=O)CC3CCC(C)(C)O3)n(C3CCC3)c2n1.Cc1ccc2nc(NC(=O)CCOC(C)C)n(C3CCC3)c2n1.
What is the InChIKey of N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide?
The InChIKey is KURMDRXZGRNSBH-HHUWXINPSA-N. The full InChI is InChI=1S/C19H27ClN4O2.C19H26N4O2.C18H25ClN4O3.C17H25ClN4O2.C17H24N4O2/c1-18(2,3)24-16-13(8-9-14(20)22-16)21-17(24)23-15(25)11-12-7-6-10-19(4,5)26-12;1-12-7-8-15-17(20-12)23(13-5-4-6-13)18(21-15)22-16(24)11-14-9-10-19(2,3)25-14;1-18(2,3)26-11-8-15(24)22-17-20-13-4-5-14(19)21-16(13)23(17)12-6-9-25-10-7-12;1-16(2,3)22-14-11(7-8-12(18)20-14)19-15(22)21-13(23)9-10-24-17(4,5)6;1-11(2)23-10-9-15(22)20-17-19-14-8-7-12(3)18-16(14)21(17)13-5-4-6-13/h8-9,12H,6-7,10-11H2,1-5H3,(H,21,23,25);7-8,13-14H,4-6,9-11H2,1-3H3,(H,21,22,24);4-5,12H,6-11H2,1-3H3,(H,20,22,24);7-8H,9-10H2,1-6H3,(H,19,21,23);7-8,11,13H,4-6,9-10H2,1-3H3,(H,19,20,22)/t12-;;;;/m1..../s1.
What are the key properties of N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide?
N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide has a molecular weight of 1771.49 g/mol, XLogP of 19.05, 22 rotatable bonds, 5 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-tert-butyl-5-chloroimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide;N-[5-chloro-3-(oxan-4-yl)imidazo[4,5-b]pyridin-2-yl]-3-[(2-methylpropan-2-yl)oxy]propanamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-propan-2-yloxypropanamide is sourced from PubChem (CID 159245965), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).